FOLLOW US :
  • |
  • |

Equity

Daily Market Tracker
Market Analysis
Other Markets
Corporate Actions
News
Corporate Information

Corporate Results

Back
Shree Ganesh Biotech India standalone net profit declines 96.88% in the September 2025 quarter
(08-Nov-2025, 17:39 Hours IST)  
Net profit of Shree Ganesh Biotech India declined 96.88% to Rs 0.01 crore in the quarter ended September 2025 as against Rs 0.32 crore during the previous quarter ended September 2024. Sales declined 61.11% to Rs 0.77 crore in the quarter ended September 2025 as against Rs 1.98 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales0.771.98 -61
OPM %-51.951.01 -
PBDT0.010.32 -97
PBT0.010.32 -97
NP0.010.32 -97

Powered by Capital Market - Live News

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)